Locations
Cambridge, UK · Streetly End, Cambridge CB21 4RP, UK
industry
Biotechnology · DeepTech
Size
51-200 employees
Stage
Series C+
founded in
2014
Healx is a biotechnology company focused on AI-powered drug discovery for rare diseases. By leveraging advanced artificial intelligence and machine learning, Healx aims to identify new therapeutic applications for existing drugs, significantly reducing the time and cost associated with traditional drug development. Their innovative approach allows for the rapid development of a diverse pipeline of therapies, addressing the urgent need for treatments in a market where 90% of rare diseases currently lack approved therapies. Healx's commitment to patient-inspired solutions and collaboration with various stakeholders positions it as a leader in the rare disease treatment landscape.
Something looks off?